CAR-T cell Pro-biotics

We are thrilled to announce A Biotech Company - our innovative life science research venture is now launching its first groundbreaking research project in collaboration with exceptional, inspirational, and bigger-than-life institutions / academic partners.

Starting first with our collaboration between the Great Ormond Street Institute of Child Health at University College London (United Kingdom) and the Department of Biological Sciences at the Princess Nora Bint Abdul Rahman University (Kingdom of Saudi Arabia), we are proudly presenting this milestone, which kindly funded by the British Council for encouraging international collaboration and co-operation, as the start of fruitful things to follow.

Our pioneering research project will delve into the exciting frontier of using probiotics to enhance CAR-T cell therapies. CAR-T cells, a revolutionary approach in cancer treatment, modifies a patient’s T cells to better attack cancer cells. By integrating probiotics, known for their role in gut health and immune system modulation, we aim to boost the efficacy and safety of these life-saving treatments.

This collaboration marks a significant milestone for A Biotech Company. We are not just exploring scientific curiosities; we are transforming innovative research into transformative medicines and therapies. The potential impact on patient outcomes is immense, promising a future where advanced therapies are safer, more effective, and accessible.

Stay tuned for exciting new and upcoming updates on this project and others to come as we embark on this journey to push the boundaries of science, technologies, and the improvement to lives worldwide.

Meet The Researchers

  • Researcher and Co-Lead

    Abeer Al Hubaysh, holds an Undergraduate degree in Biological Sciences from Princess Nourah University, Riyadh, Saudi Arabia. Abeer has also earned a Master of Science in Biomedical Engineering from the Washingon, D.C, before completing her PhD in Biochemical Engineering of Cell and Gene Therapies from University College London, United Kingdom. Abeer is an award-winning associate professor at Princess Noorah University and a Fellowship member at MISK. Abeer is recognised as the 1st female from Saudi Arabia to study and research CAR-T manufacturing internationally.

  • Research

    Vaques George, earned his undergraduate degree in Bioprocessing of New Medicines from University College London. He also holds a Master of Research in Biomedicine from Great Ormond Street Institute of Child Health and a PhD in Biochemical Engineering of Regenerative Medicines from UCL on the topic of bioprocessing of gamma-delta T cells and extracellular vesicles.

  • Research Co-Lead and Supervisor

    Mona is an Associate Professor of Infection, Immunity & Inflammation at the Great Ormond Street Institute of Child Health with decades of experience in gut microbiome immunology and therapeutic potential. Mona shares great interests in gut-microbiome status, infant development and antimicrobial resistance.